Status:
ENROLLING_BY_INVITATION
Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability
Lead Sponsor:
Stanford University
Conditions:
Metabolic Diseases
Infertility
Eligibility:
All Genders
1-75 years
Brief Summary
This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This st...
Detailed Description
It is thought that studies of genetic reprogramming and SCNT using human cells have the potential to give us new basic knowledge about human development. Current work will focus on developing this bas...
Eligibility Criteria
Inclusion
- Donors with a degenerative disease phenotype or genetic disorders such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian failure)
Exclusion
- Unable to read or understand English. 2. Unable to provide skin biopsy sample due to skin condition in the underarm area.
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00628199
Start Date
September 1 2007
End Date
January 1 2030
Last Update
August 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305